Background/Aims: Increased endoplasmic reticulum (ER) stress contributes to development of cardiorenal syndrome (CRS), and Silent Information Regulator 1 (SIRT1), a class III histone deacetylase, may have protective effects on heart and renal disease, by reducing ER stress. We aimed to determine if SIRT1 alleviates CRS through ER stress reduction. Methods: Wild type mice (n=37), mice with cardiac-specific SIRT1 knockout (n=29), or overexpression (n=29), and corresponding controls, were randomized into four groups: sham MI (myocardial infarction) +sham STNx (subtotal nephrectomy); MI+sham STNx; sham MI+STNx; and MI+STNx. To establish the CRS model, subtotal nephrectomy (5/6 nephrectomy, SNTx) and myocardial infarction (MI) (induced by ligation of the left anterior descending (LAD) coronary artery) were performed successively to establish CRS model. At week 8, the mice were sacrificed after sequential echocardiographic and hemodynamic studies, and then pathology and Westernblot analysis were performed. Results: Neither MI nor STNx alone significantly influenced the other healthy organ. However, in MI groups, STNx led to more severe cardiac structural and functional deterioration, with increased remodeling, increased BNP levels, and decreased EF, Max +dp/dt, and Max -dp/dt values than in sham MI +STNx groups. Conversely, in STNx groups, MI led to renal structural and functional deterioration, with more severe morphologic changes, augmented desmin and decreased nephrin expression, and increased BUN, SCr and
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Introduction
Cardiac and renal diseases share several risk factors, and are physiologically interlinked. Although physicians have long recognized that dysfunction of either heart or kidney seldom occurs in isolation, only recently has the concept of the cardiorenal syndrome (CRS), along with a classification system, been proposed [1] . Studies have shown close heart-kidney interactions, for example chronic kidney dysfunction (CKD) increases risk for cardiovascular events, and patients with chronic heart failure (CHF) and microalbuminuria or CKD have worse outcomes than those with CHF alone [2] [3] [4] . However, the underlying mechanisms remain poorly understood and therapeutic options are limited.
Hemodynamic changes are probably the most evident contributors to heart-kidney interactions. Other mechanisms implicated in CRS pathogenesis include sympathetic over-activity, renin-angiotensin-aldosterone axis changes, oxidative injury and endothelial dysfunction, anemia, inflammation and obesity [5] . Furthermore, we have shown that myocardial infarction (MI) worsened glomerular injury and microalbuminuria in rats with pre-existing renal impairment, with a crucial role being played by activation of endoplasmic reticulum (ER) stress [6, 7] .
Silent Information Regulator 1 (SIRT1), a nuclear and cytoplasmic class III histone deacetylase, regulates a wide variety of cellular processes [8, 9] . In vitro and in vivo studies have shown that: (1) SIRT1 activation was protective of cardiac and renal function under stress conditions [10, 11] , (ii) SIRT1 deficiency was associated with pathophysiologic changes in cardiovascular and renal disease [11, 12] , and (3) SIRT1 attenuated ER stress in both heart and kidney [13, 14] .
We hypothesized that the protective effect of SIRT1 on cardiac and renal function is effected through its modulation of ER stress. We tested this hypothesis by using genetically altered mice, in which cardiac expression of SIRT1 was either upregulated or downregulated in CRS models, to investigate if the protective effect of SIRT1 on cardiac and renal function is through its modulation of ER stress.
Materials and Methods
Animal preparation
In our study we used four types of male mice: (1) wild type (WT) C57BL/6 (Experimental Animal Center, Fudan University, Shanghai, China), (2) cardiac-specific SIRT1 knockout (CKO), (3) cardiac-specific SIRT1 pre-overexpression transgenic (Tg), and (4) their corresponding control littermates (Shanghai Biomodel Organism Science and Technology Development Co., Ltd).
Mice were acclimatized for two weeks before the start of the experiment, in the same housing used during the experiments, namely a pathogen-free facility under controlled temperature (24 ± 2°C) and humidity (50 ± 5%), with a 12-hour light/dark cycle. At the start of the experiments, mice were 8-10 weeks of age and weighed 18-22g. The animal research study protocols complied with the guide for the care and use of laboratory animals published by the National Institutes of Health in the USA, and were approved by the Animal Care Committee of Shanghai Sixth Hospital, Shanghai Jiaotong University School of Medicine in China.
Experimental protocols 1. Creation of transgenic mouse model (cardiac-specific SIRT1 knockout or overexpression).
To generate cardiac-specific SIRT1-knockout mice, mice carrying a floxed Sirt1 allele (Sirt1 flox/flox ; Jackson Laboratory), (in which exon 4 of Sirt1 was flanked by loxP sites), were crossed with Myh6-Cre + transgenic mice (B6. FVB(129)-Tg (Myh6-cre/Esr1*) 1Jmk/JSmoc, (Shanghai Biomodel Organism Science and Technology Development Co., Ltd, Shanghai, China) expressing Cre recombinase under the control of the Myh6 promoter. Genotyping was confirmed by PCR from genomic DNA prepared from tail biopsies. All mice were kept on a full C57BL/6 background.
For the detection of Sirt1 protein, we firstly used a monoclonal antibody produced by immunizing rabbit with a synthetic peptide corresponding to residues surrounding Phe297 of human Sirt1 protein, according to the manufacturer's instructions (Cell Signalling, Beverly, MA, USA. #9475, species reactivity: human, mouse, rat, monkey), which may also recognize the region encoded by exon 4 of mouse Sirt1 (aa 256-306). Secondly, although deletion of exon 4 should result in expression of a truncated form of sirt1 with similar molecular weight, several studies with similar Sirt1 knockout mice models, (generated by in-frame deletion of exon 4), have shown that the cardiac expression of Sirt1 was significantly reduced, while the epitopes of Sirt1 antibodies were not clearly stated [15, 16] . Lastly, to confirm the deletion of exon 4, we performed quantitative RT-PCR analyses using total RNA prepared from cardiac tissue, using primer specific for exon 4. The results showed that the expression of full-length Sirt1 (with exon 4) was significantly reduced in the Sirt1 KO group compared to the control group.
The model for overexpression of Sirt1 was created through intramyocardial injection of lentivirus vectors containing sirt1 cDNA (Hanbio, Shanghai, China). Viral supernatant was generated by 293FT cells transfected with EX-Lv105 plasmid and lentiviral packaging plasmids. Viral titers were determined with a quantity kit. The C57BL/6 mice were anesthetized by intraperitoneal injection of pentobarbital (50mg/ kg) followed by intubation and mechanical ventilation with room air. A thoracotomy was performed at the left fourth intercostal space to expose the anterior left ventricular (LV) wall. A total volume of 20 μl virus containing solution (1×10 8 pfu/ml) was injected into four different sites (5 μl each) around the anterior LV wall, through a sterile Hamilton syringe with a 30-gauge sterile beveled needle, under visual guidance. The syringe was held in place until the bleb formed by the solution disappeared. Then the needle was removed, and the chest wall was closed.
2. Experimental groups. The mice of each of the WT, CKO, and Tg lines (see "Animal Preparation" above) were randomized into four procedure groups: (1) sham MI + sham STNx; (2) MI + sham STNx; (3) sham MI + STNx; and (4) MI + STNx (MI, myocardial infarction; STNx, subtotal nephrectomy).
Procedures to induce chronic renal dysfunction and myocardial infarction.
We initially generated a model of subtotal nephrectomy (5/6 nephrectomy, SNTx). Four weeks later, MI was induced. After a further four weeks, we conducted echocardiographic and hemodynamic studies, and then the mice were sacrificed and their tissues harvested for histopathology and immunohistochemistry, ELISA, and Western-blot studies.
Induction of chronic renal dysfunction
A subtotal nephrectomy to create a model of chronic renal dysfunction (STNx) or a sham operation, was performed on eight-week old WT, KO and Tg mice. The STNx was accomplished by a two-step surgical procedure, with an interval of one week between the steps; for each step the mice were anesthetized by intraperitoneal injection of pentobarbital (50mg/kg), [17] . In the first step, two to three arterial branches of the left kidney were ligated, leaving an intact kidney segment. In the second step, the right kidney was removed. Thereafter, the mice received 0.9% NaCl in their drinking water. The sham STNx mice received similar skin incisions and sutures in one week apart.
To confirm kidney injury before sacrifice, serum and urine samples were collected to assess changes in blood urea nitrogen (BUN), serum creatinine (SCr), and urinary albumin to creatinine ratio (UACR).
Cellular Physiology and Biochemistry
Induction of myocardial infarction
Four weeks after the STNx or sham STNx operation, we performed a left anterior descending (LAD) ligation or sham-ligation [18] . Briefly, anesthesia was induced with isofurane (2% for 6-8 mins), and the depth of anesthesia was monitored by tail pinch reflex. Mice were intubated with a 22f tube, and ventilated with a rodent ventilator (model 687; Harvard Apparatus Inc., MA, USA) at 100 breaths/min with room air. The mice were kept warm with heat lamps. Rectal temperature was monitored, and maintained between 36°C and 37°C. The chest was opened by a horizontal incision at the third intercostal space. Heart exposure was performed by a thoracotomy at the fourth left intercostal space. After removing the pericardial sac, MI was induced by ligating the LAD branch of the left coronary artery with an 8-0 Prolene suture, with silicon tubing (1 mm outer diameter) placed on top of the LAD coronary artery, 2 mm below the border between the left atrium (LA) and left ventricle (LV). Ischemia was confirmed by electrocardiogram (ECG) change (lead II, ST elevation). After LAD ligation, the rib space, overlying muscles, and skin were closed. When recovered from anesthesia, the mice were extubated and returned to their cages. The mice were then housed in a climate-controlled environment for four weeks. The sham MI mice received only a similar procedure of chest opening and closure without ligation of LAD.
Transthoracic Echocardiography
Transthoracic echocardiographic (TTE) examination was performed, four weeks after the induction of MI, using a Vevo 2100 micro imaging system with a MS400 30-MHz linear array transducer (VisualSonics Inc., Toronto, Canada). For the TTE procedure, mice were anesthetized by intraperitoneal injection of pentobarbital sodium (50 mg/kg), and placed supine on a platform with a heating unit to maintain their body temperature at 37.0±0.5°C. Heart rate (HR) was continuously monitored by ECG electrodes. Both parasternal long-axis and short-axis views were performed. The M-mode from the long axis view was obtained to measure increased interventricular septal (IVS) thickness, and the M-mode from the short axis view was performed to measure thickness of LV anterior wall (LVAW), LV posterior wall (LVPW), LV end-diastolic diameter (LVEDD), and the LV end-systolic diameter (LVESD). End-diastolic and end-systolic measurements were obtained at the time of maximal and minimal internal chamber dimensions, respectively. In addition, LV ejection fraction (EF) value, fractional shortening (FS), and LV mass were calculated, as previously described [19] . All measurements were repeated thrice from at least 10 consecutive cardiac cycles, and were analyzed by a single observer blinded to the treatment protocol, according to the recommendations of the American Society of Echocardiography [17, 20] . The mean values were used for data analysis.
Hemodynamic measurement
Four weeks after the induction of MI, all mice were anesthetized with isofurane, intubated and ventilated for cardiac catheterization procedures [21] . The mice were placed supine on a platform with a heating unit. The body temperature was maintained at 37.0±0.5°C to minimize heart rate variation. The right carotid artery was cannulated with a 1.2F pressure catheter (Transonic, Ithaca, NY, USA), which was passed retrogradely into the LV. The LV pressure tracings were digitized with a PowerLab physiological recorder (AD Instruments, Australia), and stored in a computer for off-line analysis. Left ventricular enddiastolic pressure (LVEDP), the maximum/minimum first derivative of LV pressure over time (± dP/dt max ), and mean arterial pressure (MAP), were analyzed in a blinded fashion, with dedicated software (LabChart 8).
Sample collection
To monitor urinary volume change, 24 hr urine samples were collected, by using the metabolism cage, at baseline and every four weeks from the beginning of the study. Urine samples were stored at -20°C. Urinary albumin and creatinine concentrations were measured with assay kits (Shibayagi, Japan). The urinary albumin to creatinine ratio (UACR) was calculated by using a formula based on albumin and creatinine levels.
After taking the hemodynamic measurements, blood samples were collected (under anesthesia by intraperitoneal injection of pentobarbital sodium (50 mg/kg)), and the enterocoelia were cut off to expose the inferior vena cava. The blood samples were collected in heparinized microtubes and centrifuged at 3000r/s for 15 mins (3K30, Sigma, USA). The SCr, and BUN levels were measured using the enzymatic method. Plasma brain natriuretic peptide (BNP) was measured with an AssayMaz mouse BNP-45 (mBNP-45) assay kit (Phoenix Pharmaceuticals, Inc, CA, USA). 
Histological Examination and Immunohistochemistry
Four weeks after the MI surgery, all mice were sacrificed by injection of pentobarbital sodium (50 mg/ kg). Immediately after collection of a plasma sample from the inferior vena cava (as mentioned in sample collection), the chest was opened. The LV of the heart and left residual kidney were collected and weighed. Tissues were cut in half; one half was snap frozen in liquid nitrogen for western-blot (see below), the other half was fixed in neutral buffered formalin, and processed for histopathology and immunohistochemistry.
Among the second half of collected tissue samples, half of them were then homogenized in 10% buffered paraformaldehyde, and processed for hematoxylin-eosin (HE) or Masson dye staining. Tissue sections (1μm thick) were stained by Mallory and viewed using a light microscope (Leica, Frankfurt, Germany) with a computer-assisted analyzer (Image Pro Express system, USA). Focal interstitial fibrosis was defined as an increase in matrix deposition in interstitial spaces that was distinguishable from the surrounding area (perivascular areas were excluded).
Immunohistochemistry was used to assess desmin, TGF-β1, and nephrin expression in the kidney. Tissues were fixed with 10% paraformaldehyde and embedded in paraffin, sectioned into 4 µm-thick slices, and stained with periodic acid-Schiff reagent. Immunohistochemistry was performed as previously described [22] , using a primary antibody against desmin, TGF-β1 and nephrin (Abcam, Cambridge, United Kingdom), followed by the Nichirei simple stain kit (Nichirei, Messe Düsseldorf, Germany). Immunological changes were quantified by positive diaminobenzidine staining, with scoring from 0 to 5 by double-blinded histologists.
Enzyme linked immunosorbent assay (ELISA)
Blood was collected in heparinized microtubes rapidly after exposure of the inferior vena cava and subjected to centrifugation (3000r/s) (Sigma, USA). The three immunosorbent plasma assays performed were BNP (mBNP-45, ASSAYPRO, USA), UACR, and BUN using the enzymatic method by Sirolimus.
Western-blot
For immune-blot analysis, heart and kidney samples were homogenized in lysis buffer (50 mmol/L Tris-HCl, pH 7.4, 0.1% sodium dodecyl sulfate, 1% Igepal CA-630, 0.15 mol/L NaCl, 0.25% Na-deoxycholate, and 1 mmol/L EDTA supplemented with protease inhibitors). Cardiac and renal cortical tissue (30 mg) was homogenized with 1 ml of modified RIPA buffer in the presence of protease and phosphatase inhibitors. Equal amounts of protein (30μg) were separated by 10% SDS-PAGE, and electrophoretically transferred to nitrocellulose membranes (Amersham Biosciences, Piscataway, NJ, USA). Western-blot analysis was performed with specific antibodies as per the manufacturer's protocol. Antibodies used to assess ER stress in heart and kidney were directed at CHOP, GRP78, p53, and BAX. As controls we used tubulin, GAPDH (Cell Signal Technology), and β-actin (Calbiochem, Germany).
Statistical Analysis
Statistical analysis was performed using SPSS 13.0 for Windows (SPSS Inc, Chicago, USA). Continuous variables were expressed as mean ± SEM, and were compared using the t-test. For comparisons among multiple groups, we used one-or two-way ANOVA and Bonferroni post-test. A two-tailed P value of < 0.05 was considered statistically significant. Table 2) and Max -dp/dt (-3515.8±431.7 vs. -5917.64±775.3 mmHg/s, P<0.05) ( Table 2) , indicating worsened cardiac remodeling in the MI + STNx group. A significant remodeling of cardiac tissue seen in H&E staining (Fig. 1 B) , and a higher mean score for Masson staining of the heart (6.23±1.02 vs. 5.5±0.79, P<0.05) was also observed in MI + STNx group than in the MI + sham STNx group (Fig. 1 A, C) , indicating a higher degree of fibrosis in the MI +STNx compared group to the MI + sham STNx group. These changes were (Fig. 1D ).
Results
Greater structural and functional deterioration of the heart and kidney after concomitant injuries vs. isolated injury
In the MI + STNx group compared to the sham MI + STNx group, the residual kidney showed greater degree of glomerular swelling, mesangial hyperplasia, and disintegration with cristae in podocytes ( Fig. 2 A) ; and a higher degree of renal fibrosis, and higher levels of desmin, TGF-b1, BUN, SCr and UACR, and significantly lower levels of nephrin (Fig. 2 A-L) . However, induction of MI alone did not affect renal structure or function in mice without STNx four weeks post-MI. Furthermore, STNx alone had no significant influence on cardiac structure and function.
Cardiac-specific overexpression of SIRT1 protected both the heart and the kidney in CRS After induction of both MI and STNx, the SIRT1 knockout (KO) mice had: (1) Table  4 ), indicating worsened cardiac remodeling in the SIRT1 KO MI + STNx group compared with the KO control MI +STNx group. A significant remodeling in heart H&E staining (Fig. 3  B) , and higher score for Masson staining of the heart (8.82±0.96 vs. 5.71±1.62, P<0.05) was also observed in SIRT1 knockout group (Fig. 3 A, C) , indicating a higher degree of fibrosis in the SIRT1 KO MI + STNx group compared to the KO control MI + STNx group. These changes were further supported by a significantly higher BNP level (631.43±142.99pg/ml vs. 498.43±93.16pg/ml, P<0.05) (Fig. 3 D) Fig. 3 A) , after induction of both MI and STNx compared with the WT control group that had undergone the same operations. Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
In the residual kidney, the CKO group showed a higher degree of glomerular swelling, mesangial hyperplasia, and disintegration with cristae in podocytes, compared to their WT control group in H&E staining (Fig. 4 A) , and a significantly higher Masson-staining score (7.43±1.37 vs 3.35±1.13, P<0.01) (Fig. 4 B) , indicating a greater extent of renal cortical fibrosis in the CKO group (Fig. 4 B) . Significantly increased expression of desmin and TGF-β1 (7.01±0.89 vs. 5.2±1.10, P<0.05; 5.97±0.82 vs. 5.48±1.03, P<0.05, respectively) (Fig. 5 A-D) , along with significantly decreased expression of nephrin (0.71±0.17 vs. 3.08±0.69, P<0.05) were also present in the CKO MI+ STNx group compared with CKO control MI + STNx group (Fig. 5 E,F) (Fig. 4 D-F) .
In contrast, the kidney in mice in the SIRT1 overexpression group, presented with significantly less severe renal structural and functional alteration after induction of both MI and STNx, as evidenced by lower Masson score (2.84±0.43 vs. 3.38±0.59, P<0.05) (Fig. 4  B) , increased expression of desmin and TGF-β1 (5.51±0.43 vs. 3.01±0.72, P<0.05; 5.81±0.87 vs. 3.96±0.92, P<0.05, respectively) ( Fig. 5 A-D) , and decreased UCAR (13.91±1.44 vs. 17.81±1.53 µg/mg, P<0.05, Fig. 4 F) (Fig. 4 D, E) .
ER stress is involved in CRS and modulated by SIRT1
We evaluated the activation of ER stress in both the heart and the kidney through detection of four proteins. In groups that had undergone both MI and STNx, the CKO group showed significantly higher levels of CHOP and GRP78 expression within the myocardium than did the related WT control group (2.59±0.37 vs. 1.53±0.29, P<0.05; 3.17±0.36 vs. 1.96±0.28, P<0.05, respectively) (Fig. 6 A-D) . In contrast, SIRT1 overexpression within the (Fig. 6 A-D) .
In the residual kidney, the CKO group showed significantly higher levels of CHOP, Bax and p53 expression than did the related WT control group (2.64±0.23 vs. 1.74±0.17, P<0.05; 1.49±0.11 vs. 0.96±0.17, P<0.05; 1.84±0.17 vs. 0.77±0.09, P<0.01, respectively) ( Fig. 7 A-F (Fig. 7 A-F) .
Discussion
Interactions between MI and STNx and their effects on cardiac and renal structure and function
The term "cardio-renal syndrome (CRS)" identifies a disorder of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction [2, [24] [25] [26] [27] .
In the present study, we studied CRS in mice with Sirt1 cardiacspecific knock out or overexpression, and showed that induction of either STNx or MI aggravated structural and functional deterioration of the other organ. These findings reflect the clinical progression of CRS, in which the onset of renal or cardiac dysfunction may worsen the outcome of pre-existing dysfunction of the other organ. However, induction of MI alone did not affect renal structure or function in mice without STNx 28 days post-MI, which might be explained by the relatively preserved EF value in our MI model being insufficient to cause acute or sub-acute renal dysfunction. Likewise, STNx alone had no significant influence on cardiac structure and function, which was in accordance with a previous study in rats [28] . 
ER stress plays an important role in CRS
Protein synthesis in the ER is of great importance for the normal functioning of both the heart and the kidney [29, 30] . The dysregulation of protein synthesis and/or protein processing within the ER causes the accumulation of unfolded proteins which triggers the unfolded protein response (UPR). The UPR involves multiple mechanisms through which the accumulated unfolded proteins are eliminated, by increasing ER resident chaperones, inhibiting protein translation, and accelerating the clearance of unfolded proteins. However, if ER stress exceeds the capacity of these adaptive mechanisms, the ER initiates apoptotic signaling, which may lead to cell death [31, 32] . Previous studies suggested that ER stress was triggered in diseases affecting either the heart or the kidney, and played a part in the pathological process of these diseases [33] [34] [35] [36] [37] [38] .
In our present study, induction of either MI or STNx increased expression of GRP78 and CHOP in the associated organ, suggesting that activation of ER stress could underlie the progression of cardiac and renal dysfunction in the settings of CRS. Moreover, induction of MI resulted in higher levels of BAX and CHOP expression in the kidney of mice that had undergone STNx as compared to those that had received MI only, which was in accordance with our previous study in rats [6] . In contrast, within the post-MI myocardium, the mice that underwent STNx presented with higher levels of GRP78 and CHOP expression, as compared to the group that had undergone a sham operation to the kidney. The latter interactions between the heart and the kidney may form a vicious cycle, resulting in significant upregulation of ER stress and subsequent cell death in both organs. However, based on current evidence, we are unsure if the activation of ER stress after stimulus to the other remote organ was merely a manifestation of hemodynamic interactions, or if there were other signal-transduction pathways involved.
Cardiac specific overexpression of SIRT1 modulates ER stress to attenuate post-MI remodeling and improve renal function in CRS
SIRT1 is a member of the Sirtuin family, which is a highly conserved family of histone/ protein deacetylases belonging to the class-III group of HDACs [8] . SIRT1 regulates a wide array of cellular processes that are pivotal in the regulation of cellular survival, senescence and metabolism, through deacetylation of a growing list of histones and non-histone proteins [39] . Emerging evidence from in vitro and in vivo studies indicates that activation of SIRT1 displays pro-survival activity in both the heart and the kidney, and protects both organs from stress [11, [40] [41] [42] [43] [44] . In the present study using cardiac-specific SIRT1 knockout and overexpression, we showed that cardiac-specific SIRT1 knockout or overexpression aggravated or attenuated, respectively, the cardiac and renal remodeling/dysfunction in the setting of CRS.
Several studies had demonstrated that activation of SIRT1 attenuates ER stress in both the heart [14, 45] and the kidney [13, 46] . In our current study, cardiac expression of GRP78 and CHOP, and renal expression of CHOP, BAX and p53, were significantly increased in cardiac-specific SIRT1 knockout mice, whereas cardiac-specific SIRT1 overexpression had opposite effects. The latter results indicate that SIRT1 may exert its protective activity through modulation of ER stress in both the heart and the kidney, although the exact underlying mechanism was not investigated. According to previous studies, deacetylation of key transcriptional factors of UPR such as eIF-2αor XBP-1 may be involved [45, 46] .
Potential clinical implications
Patients with CKD are frequently excluded from randomized controlled clinical trials of drugs to treat chronic congestive heart failure [47] , limiting the evidence on therapeutic efficacy for the management of patients with CRS. Current treatment for chronic heart failure involves many therapeutic approaches that may adversely affect renal function [48] . The present study showed that activation of SIRT1 alleviated both cardiac and renal remodeling/ dysfunction in the setting of CRS through modulation of ER stress, indicating that SIRT1 activating compounds such as resveratrol potentially could be used for treatment of CRS. 
Limitations
According to previous studies, hemodynamic alternations after induction of MI play a significant part in the progression of CRS [24] . However, in our current study, hemodynamic changes post MI were not restricted, contrasting with previous reports [2] . We observed that induction of either MI or STNx caused activation of ER stress in the other organ. However, based on current evidence, we are unsure if the activation of ER stress after stimulus to the other remote organ was merely a manifestation of hemodynamic interactions, or if there were other signal-transduction pathways involved. Lastly, although our findings indicated that SIRT1 may exert its protective activity through modulation of ER stress in both the heart and the kidney, we did not investigate the exact underlying mechanism(s).
Conclusion
In summary, the present study documented that induction of both MI and STNx aggravated structural and functional deterioration of the other organ, and caused activation of ER stress in both organs. Cardiac-specific knockout of SIRT1 upregulated ER stress in both the heart and the kidney and aggravated cardiac and renal remodeling/dysfunction, whereas cardiac-specific SIRT1 overexpression downregulated ER stress in both organs thereby attenuating cardiac and renal remodeling/dysfunction. The latter findings may shed novel insight into the mechanism underlying interactions between the heart and the kidney in the setting of CRS, and may provide new therapeutic targets.
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